 |
|
Stephen H. Rusckowski |
Stephen H. Rusckowski will succeed Surya N. Mohapatra, PhD, as president and CEO of Quest Diagnostics Inc, effective May 1, 2012. Mohapatra will remain in his role through April 30 to ensure a smooth leadership transition. Rusckowski will also become a member of the board of directors.
The company also announced that Daniel C. Stanzione, PhD, currently lead independent director, will become non-executive chairman of the board, effective May 1, 2012.
Rusckowski is currently CEO of Philips Healthcare, a position he has held since 2006. He has also been a member of the board of management of Royal Philips Electronics and its executive committee.
During Rusckowski’s tenure as CEO of Philips Healthcare, revenues increased from approximately 6 billion Euro in 2005 to approximately 9 billion Euro in 2011, accounting for approximately 39% of Philips consolidated revenues, from 21% when he became CEO. Prior to his current role, Rusckowski was CEO of the Imaging Systems business group within the company. Before joining Philips he held numerous management positions with the health care division of Hewlett-Packard/Agilent Technologies. He joined Philips when it acquired Agilent’s Healthcare Solutions Group in 2001.
Rusckowski earned a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute and a Master of Science degree in Management from the Massachusetts Institute of Technology’s Sloan School of Management.
Source: Quest Diagnostics
